Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trabectedin vs Dacarbazine in Advanced Liposarcoma or Leiomyosarcoma
NCT01692678Phase 3Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Aug 2012
- Primary completion
- Oct 2016
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of trabectedin in Liposarcoma, leiomyosarcoma (LMS), sponsored by Janssen Pharmaceutical. Started Aug 2012; status: completed.
02
Drugs
trabectedin
03
Conditions
Liposarcomaleiomyosarcoma (LMS)
Beyond the preview
Go deeper on NCT01692678.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01692678.